In previous studies, there were debates on the association between handgrip strength (HGS) and prevalence of metabolic syndrome. Since body weight is associated with both HGS and prevalence of metabolic syndrome, whether HGS is corrected with body weight (relative HGS) or not (absolute HGS) can directly influence outcome of the study. Therefore, this study analyzed the relationship between HGS and prevalence of metabolic syndrome using both relative and absolute HGS. A total of 1009 Korean adults (488 men and 521 women) were analyzed. Participants were categorized into three groups according to HGS levels. Logistic regression analysis was used to calculate odds ratio (OR) and 95% confidence interval (CI) of metabolic syndrome associated with both relative and absolute HGS. Lower absolute HGS was associated with lower prevalence of having abnormal blood pressure (OR: 0.60, 95% CI: 0.37-0.97) and glucose levels (OR: 0.54, 95% CI: 0.34-0.88) in men. However, no association was found between absolute HGS and prevalence of metabolic syndrome. However, a significant inverse association was found between relative HGS and prevalence of metabolic syndrome. Compared with participants in the highest tertile, those in the lowest tertile of relative HGS had 2.52 times (95% CI: 1.43-4.46) and 5.01 times (95% CI: 1.66-15.08) higher prevalence of metabolic syndrome in men and women, respectively. Lower relative HGS but not absolute HGS was associated with higher prevalence of metabolic syndrome. Our study showed that there are evident discrepancies in the association between HGS and prevalence of metabolic syndrome whether HGS is corrected by body weight or not.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/met.2018.0111 | DOI Listing |
Sci Rep
January 2025
Medical Innovation Center, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17, Yongwai Main Street, Nanchang, 330006, Jiangxi, China.
Traditional epidemiological studies are susceptible to confounding factors. To clarify the impact of metabolic syndrome and its diagnostic components on hepatocellular carcinoma, we conducted a preliminary mendelian randomization analysis with metabolic syndrome and its diagnostic components as exposures and hepatocellular carcinoma as the outcome. Another set of genetic data related to hepatocellular carcinoma was used as a validation cohort, repeating the mendelian randomization analysis and combining the two groups for a meta-analysis.
View Article and Find Full Text PDFRev Invest Clin
January 2025
Department of Molecular Immunobiology, Centro de Investigación Biomédica, Torreón, Coah., Mexico.
Background: The effective use of combination antiretroviral therapy (ART) has significantly improved the life expectancy of people living with the human immunodeficiency virus (HIV). However, complications have shifted from opportunistic infections to issues such as drug toxicity and resistance, as well as an increase in premature cardiovascular diseases (CVD). These conditions are attributed to chronic immune activation and persistent inflammation caused by HIV, along with lipid abnormalities and insulin resistance.
View Article and Find Full Text PDFBackground: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure (HF), particularly when compounded by medications like Angiotensin converting inhibitors, Angiotensin receptor blockers, and potassium sparing diuretics.
View Article and Find Full Text PDFDiabetes
January 2025
Department of Biology & Institute of Biochemistry, Carleton University, Ottawa, ON, Canada.
Cancer survivors have an increased risk of developing Type 2 diabetes compared to the general population. Patients treated with cisplatin, a common chemotherapeutic agent, are more likely to develop metabolic syndrome and Type 2 diabetes than age- and sex-matched controls. Surprisingly, the impact of cisplatin on pancreatic islets has not been reported.
View Article and Find Full Text PDFPediatr Nephrol
January 2025
Nephrology, Children's National Hospital, 111 Michigan Avenue NW, Washington, DC, 20010, USA.
Background: Obesity and metabolic syndrome (MS) accelerate arterial stiffening, increasing cardiovascular (CV) risk after transplant. BMI is limited by inability to differentiate muscle, fat mass, and fat distribution patterns. The aim of this study was to identify the best anthropometric measure to detect arterial stiffness as assessed by pulse wave velocity (PWV) in a racially diverse pediatric transplant population.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!